Diagnostic utility of pleural fluid eosinophilia

J. Nasilowski, R. Krenke, B. Abouchaz, T. Przybylowski, R. Chazan (Warsaw, Poland)

Source: Annual Congress 2002 - Pleural problems
Session: Pleural problems
Session type: Thematic Poster Session
Number: 2791
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
J. Nasilowski, R. Krenke, B. Abouchaz, T. Przybylowski, R. Chazan (Warsaw, Poland). Diagnostic utility of pleural fluid eosinophilia. Eur Respir J 2002; 20: Suppl. 38, 2791

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Incidence and diagnostic utility of pleural fluid eosinophilia
Source: Annual Congress 2008 - Diagnostic and therapeutic approaches in pleural diseases
Year: 2008

Diagnostic utility of IL-6 in the pleural fluid
Source: Eur Respir J 2002; 20: Suppl. 38, 418s
Year: 2002

Diagnostic accuracy of pleural fluid NTpro-BNP for pleural effusions of cardiac origin
Source: Annual Congress 2012 - Novelties in clinical management of thoracic diseases: from diaphragm to pleura
Year: 2012


Diagnostic approach to pleural effusions
Source: Annual Congress 2008 - MP7 - Diagnostic approach to pleural effusions
Year: 2008

Diagnostic assessment in tuberculous pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 413s
Year: 2005

Diagnostic usefulness of tumour markers in pleural effusions
Source: Annual Congress 2009 - Diagnosis of pleural effusions and rare tumours experience
Year: 2009


Diagnostic value of leptin in tuberculous pleural effusions
Source: Eur Respir J 2004; 24: Suppl. 48, 426s
Year: 2004

Utility of pleural fluid for predictive marker testing in malignant pleural effusion
Source: Virtual Congress 2020 – Malignant pleural effusion in 2020: understanding the biology and clinical implications
Year: 2020



Utility of pleural fluid glucose measurement in TB pleural effusions.
Source: Virtual Congress 2020 – The young, the old and extrapulmonary tuberculosis
Year: 2020


Diagnostic and prognostic utility of eosinophilic pleural effusions(PE)
Source: Eur Respir J 2002; 20: Suppl. 38, 440s
Year: 2002

Diagnostic utility of biochemical parameters in patients with pleural effusions
Source: Eur Respir J 2001; 18: Suppl. 33, 386s
Year: 2001

Evaluation of pleural fluid clot histology in the diagnosis of pleural malignancy
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Diagnostic utility of eosinophilic pleural effusion: A ten years series
Source: Annual Congress 2010 - Clinical diagnosis and management of malignant pleural effusions
Year: 2010


Serial measurement of pleural fluid ADA in tuberculous pleurisy
Source: Eur Respir J 2003; 22: Suppl. 45, 160s
Year: 2003

Diagnostic value of lactatedehydrogenase in pleural effusions
Source: Eur Respir J 2002; 20: Suppl. 38, 441s
Year: 2002

Evaluation of the utility of using pleural fluid cholesterol as a new criterion for the differential diagnosis between transudates and exudates
Source: Annual Congress 2011 - The new clinical spectrum of lung diseases: from bronchi to pleura
Year: 2011

Differential diagnosis of pleural effusion based upon the cytoanalysis of the pleural fluid
Source: Eur Respir J 2006; 28: Suppl. 50, 455s
Year: 2006

Diagnostic accuracy of pleural fluid adenosine deaminase in patients with tuberculous pleural effusion while keeping pleural biopsy as a gold standard
Source: International Congress 2016 – Non-tuberculous mycobacteria: HIV-TB co-infection and adenosine deaminase (ADA)
Year: 2016

Diagnostic value of amylase levels in pleural effusions
Source: Eur Respir J 2005; 26: Suppl. 49, 448s
Year: 2005

Critical issues in pleural fluid examinations: laboratory parameters, tumour markers and cytological methods
Source: ISSN=1025-448x, ISBN=1-904097-25-1, page=110
Year: 2002